Those who have received two doses of either the Pfizer or Moderna COVID-19 vaccine no longer need to quarantine if they come in contact with someone infected with SARS-CoV-2, according to the United States Centers for Disease Control and…

The COVID-19 vaccination is designed to elicit an immune response to the SARS-CoV-2 spike protein, teaching the body how to fight off infection. This immune response often materializes as fever, chills, headache, and fatigue. This is good…

Results from a poll taken the week of January 18 show that 88% of patients have either already sought dental care or are planning to do so. The poll, conducted by the American Dental Association Health Policy Institute (ADA HPI), also found…

During the week of February 1, the United States experienced a 25% decrease in new COVID-19 cases and a 15% reduction in the number of patients hospitalized due to COVID-19 illness. These significant drops follow 4 weeks of declines in new…

As it is estimated that at least 75% of Americans need to be vaccinated against SARS-CoV-2 in order to achieve herd immunity, the race is on to see which states can vaccinate their residents the quickest. Globally, Israel—with a population…

Developed in the United Kingdom, the COVID-19 vaccine from AstraZeneca and the University of Oxford has shown 74.6% effectiveness against the new, more contagious UK-based variant, B117, of SARS-CoV-2. The research results were published…

Johnson & Johnson (J&J) has applied for an Emergency Use Authorization (EUA)  from the United States Food and Drug Administration (FDA) for its one-shot COVID-19 vaccine, which has shown 66% efficacy in preventing moderate to severe…

As efforts to improve COVID-19 vaccination rates ramp up, more states are allowing oral health professionals to administer these immunizations after completing a certain amount of training. Currently, specially trained dental hygienists are…

It has been a year since the United States declared a public health emergency because of the rapid transmission of SARS-CoV-2. The US issued this declaration on February 3, 2020, three days following a similar statement made by the World…

A peer-reviewed study in the highly regarded journal The Lancet found that Sputnik V, a new COVID-19 vaccine developed in Russia, was 91.6% effective in preventing infection with the novel coronavirus. The study included 22,000 subjects and…